Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01697345 · OUTCOME

Number of Participants Who Continued Vaginal Testosterone Upon Completion of the Study

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy · Source last updated 2014-01-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
After 4 weeks

Groups in this outcome

Continued Vaginal Testosterone Therapy

Participants who chose to continue vaginal testosterone therapy upon completion of the study.

Did Not Continue Vaginal Testosterone Therapy

Participants who chose not to continue vaginal testosterone upon completion of the study.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Continued Vaginal Testosterone Therapy12
Did Not Continue Vaginal Testosterone Therapy12

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Continued Vaginal Testosterone Therapy11Not reportedNot reportedNot reportedNot reported
Did Not Continue Vaginal Testosterone Therapy1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        11
      2. group Id
        OG001
        value
        1
denoms
  1. counts
    1. group Id
      OG000
      value
      12
    2. group Id
      OG001
      value
      12
    units
    Participants
groups
  1. description
    Participants who chose to continue vaginal testosterone therapy upon completion of the study.
    id
    OG000
    title
    Continued Vaginal Testosterone Therapy
  2. description
    Participants who chose not to continue vaginal testosterone upon completion of the study.
    id
    OG001
    title
    Did Not Continue Vaginal Testosterone Therapy
param Type
NUMBER
reporting Status
POSTED
time Frame
After 4 weeks
title
Number of Participants Who Continued Vaginal Testosterone Upon Completion of the Study
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice